Why the study?
Can absolute myocardial blood flow be accurately measured using H215O and dynamic positron-emission tomography with a tissue fraction model?
Can absolute myocardial blood flow be accurately measured using H215O and dynamic positron-emission tomography with a tissue fraction model?
This study demonstrates a novel PET imaging technique using H215O and a tissue fraction model to quantify absolute myocardial blood flow, distinguishing normal subjects from those with triple-vessel disease.
Answers are grounded in this paper and cite their sources.
May enable noninvasive absolute MBF quantification; leaves open prospective validation before clinical adoption.
An in vivo technique was developed for measuring the absolute myocardial blood flow with H215O and dynamic positron-emission tomography. This technique was based on a new model involving the concept of the tissue fraction, which was defined as the fraction of the tissue mass in the volume of the region of interest. The myocardium was imaged dynamically by positron-emission tomography, starting at the time of intravenous bolus injection of H215O. The arterial input function was measured continuously with a beta-ray detector. A separate image after C15O inhalation was also obtained for correction of the H215O radioactivity in the blood. The absolute myocardial blood flow and the tissue fraction were calculated for 15 subjects with a kinetic technique under region-of-interest analysis. These results seem consistent with their coronary angiographic findings. The mean value of the measured absolute myocardial blood flows in normal subjects was 0.95 +/- 0.09 ml/min/g. This technique detected a diffuse decrease of myocardial blood flow in patients with triple-vessel disease.
No takes yet. Share an insight, caveat, or question.
Iida et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: